Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

CellaVision walked into its Q3 2026 report with a premium P/E of 33.8x and a reputation as a high quality hematology ...

Handelsbanken Fonder adquirió el 29 de octubre 80.000 acciones de la empresa de análisis sanguíneo CellaVision. Tras esta ...

Handelsbanken Fonder purchased 80,000 shares in blood analysis company CellaVision on October 29. Following the purchase, its holding amounts to 1,246,994 shares, corresponding to 5.23 percent of the ...

08:19 Pareto Securities hebt das Kursziel für Cellavision auf 175 Kronen (160) an und bekräftigt die Halteempfehlung FW 06:32 ...

CellaVision AB (($SE:CEVI)) has held its Q3 earnings call. Read on for the main highlights of the call. CellaVision AB’s latest earnings call struck an upbeat ...

Welcome to CellaVision Q3 report 2026. [Operator Instructions]. Now, I will hand the conference over to CEO Steve Ferguson ...

CellaVision AB a publié ses résultats pour le troisième trimestre et les neuf mois clos le 30 septembre 2026. Au troisième trimestre, le chiffre d’affaires de la société s’est établi ...

La empresa de análisis hematológico Cellavision ha presentado una facturación y un ebitda superiores a lo previsto en el ...

Blodanalysbolaget CellaVision visar återigen styrka efter vårens svacka. Försäljningen växer tvåsiffrigt och vinsten ...